Thyroid peroxidase antibodies (anti-TPO): what it means

A positive anti-TPO result on a lab report often causes alarm — but on its own it is not a diagnosis. Anti-TPO is a marker of autoimmune activity in the thyroid gland, not a direct measure of its current function. A substantial proportion of people have elevated antibodies with no thyroid dysfunction and no clinical symptoms whatsoever. Here is what this marker means, when to test for it, and when it actually carries clinical weight.

The key rule: anti-TPO is always interpreted alongside TSH. Antibodies without thyroid stimulating hormone in the picture give an incomplete story. It is TSH that determines whether the situation requires any intervention.

What thyroid peroxidase antibodies are

Thyroid peroxidase (TPO) is an enzyme produced by the thyroid gland that plays a central role in thyroid hormone synthesis: it catalyses the incorporation of iodine into thyroglobulin, from which T3 and T4 are subsequently formed. When this enzyme does not work properly, hormone synthesis is disrupted.

Anti-TPO antibodies are IgG immunoglobulins directed against this enzyme. They arise when the immune system erroneously identifies TPO as a foreign antigen. Anti-TPO is detectable in approximately 90% of patients with Hashimoto’s thyroiditis and in around 75% of patients with Graves’ disease. In addition, anti-TPO at lower concentrations is present in 10–15% of people with no thyroid disease at all — particularly among older women. The antibodies themselves are a marker of an ongoing autoimmune process, but not a direct indicator of the extent of gland damage.

Reference range and result interpretation

Threshold values vary depending on the assay method and the specific laboratory — use the reference range printed on your own report as the primary guide. The broadly accepted categories look approximately like this:

A single positive result with no TSH change is not a diagnosis — it represents an elevated risk of developing hypothyroidism in the future. NICE NG145 and the AACE/ATA 2012 guidelines agree that isolated positive anti-TPO in the absence of TSH dysfunction typically requires no treatment — only monitoring over time.

An important caveat about comparing results: absolute anti-TPO values are not interchangeable between different laboratories or different assay methods. For tracking trends, it is best to use the same laboratory and the same method each time.

Hashimoto’s thyroiditis and hypothyroidism

Hashimoto’s thyroiditis — autoimmune inflammation of the thyroid gland — accounts for approximately 80% of hypothyroidism cases in developed countries (Caturegli et al., 2014). In this condition the immune system gradually destroys thyroid tissue, which over time leads to declining function and the eventual need for replacement therapy.

The characteristic diagnostic picture — positive anti-TPO combined with elevated TSH — virtually rules out other causes of hypothyroidism; biopsy or scintigraphy is not usually required in these circumstances (AACE/ATA 2012). An ultrasound appearance of a “coarse” or “heterogeneous” gland provides additional confirmation of the diagnosis, but is not mandatory for establishing it.

If you have just received an elevated TSH result and want to understand what it means, read more in the article on the TSH test.

Pregnancy and anti-TPO

This is one of the most clinically important contexts for anti-TPO. According to the ATA 2017 guidelines (Alexander et al.), positive anti-TPO combined with subclinical hypothyroidism during pregnancy is grounds for closer monitoring and often for initiating levothyroxine replacement therapy.

Even a “normal” TSH in a pregnant woman with positive anti-TPO warrants attention: the treatment threshold during pregnancy is lower than outside it. Specifically, TSH > 2.5 mIU/L in the first trimester in a woman with positive anti-TPO may already be grounds for an endocrinology consultation and consideration of replacement therapy. Women planning a pregnancy or already in the first trimester are generally advised to check TSH and anti-TPO together — this gives a fuller picture of thyroid status.

For more detail on laboratory tests during pregnancy, see the article on pregnancy blood tests.

Should asymptomatic positive anti-TPO be treated?

No. There is currently no proven method for reducing anti-TPO levels or for proven prevention of progression to hypothyroidism. Attempts to “treat” the antibodies themselves — for example with selenium supplements or a gluten-free diet — do not have sufficient evidence to support routine recommendation.

The recommended strategy when anti-TPO is isolated and positive with a normal TSH:

• Monitor TSH every 6–12 months — to catch the point at which thyroid function begins to decline.
• Levothyroxine replacement is prescribed only when TSH rises above the normal range or clinical symptoms of hypothyroidism appear.
• The decision to start treatment rests entirely with your endocrinologist, taking into account clinical context, symptoms, and the trend in your results.

It is important to understand: the fact of positive anti-TPO does not mean you are ill or that hypothyroidism will inevitably develop. In a significant proportion of antibody carriers, thyroid function remains stable for years. Regular monitoring means you can respond promptly if the situation changes.

When and who should be tested

Anti-TPO is typically ordered in the following situations:

• Elevated TSH on first detection — to clarify the cause and differentiate between autoimmune thyroiditis and other causes of hypothyroidism.
• Planning a pregnancy or in the first trimester — particularly if TSH is > 2.5 mIU/L or there is a prior history of thyroid problems.
• Unexplained chronic fatigue combined with a mildly elevated TSH — anti-TPO confirms the autoimmune nature of the changes.
• Family history of Hashimoto’s thyroiditis or other autoimmune conditions — such as type 1 diabetes, rheumatoid arthritis, or vitiligo.

Routine screening of asymptomatic women without the above risk factors is generally not recommended — NICE NG145 does not support population-wide anti-TPO screening. A one-off measurement without clinical context yields little useful information.

How HealthLab helps track trends

Anti-TPO is a marker that matters most when followed over time alongside TSH — not in isolation, but in a shared time context. A single result gives a snapshot, but a series of measurements reveals whether autoimmune activity has stabilised or continues to rise.

HealthLab automatically recognises anti-TPO, TSH, free T4, and other thyroid markers from PDF lab reports issued by any laboratory, and plots each on a chart with reference range boundaries. You see the full picture at a glance, without entering any data manually.

Download HealthLab on the App Store

Frequently asked questions